...
首页> 外文期刊>Acta Obstetricia et Gynecologica Scandinavica: Official Publication of the Nordisk Forening for Obstetrik och Gynekologi >Live birth and miscarriage rate following intracytoplasmic morphologically selected sperm injection vs intracytoplasmic sperm injection: An updated systematic review and meta-analysis
【24h】

Live birth and miscarriage rate following intracytoplasmic morphologically selected sperm injection vs intracytoplasmic sperm injection: An updated systematic review and meta-analysis

机译:患有IntractoPlasmic形态学选择的精子注射率为患有血液节内精子注射的活产和流产率:更新的系统审查和META分析

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction Intracytoplasmic morphologically selected sperm injection (IMSI) is one of the sperm selection techniques used for assisted reproduction which has been applied for a variety of indications including previously failed fertilization with intracytoplasmic sperm injection (ICSI). A Cochrane review(1) found no difference in outcomes between either modality of sperm selection. Since the Cochrane review was published there have been a further two randomized controlled trials comparing IMSI and ICSI. This systematic review and meta-analysis aims to compare IMSI with ICSI as insemination methods regarding live birth rate and miscarriage rate. Material and methods Systematic review of randomized controlled trials, observational studies and similar reviews in electronic databases published before January 2018. Results We found nine randomized controlled trials, evaluating 1610 cycles of in vitro fertilization and 15 observational studies evaluating 1243 cycles of in vitro fertilization. Meta-analysis of the included randomized controlled trials showed no difference in the live birth rate or miscarriage rate between the ICSI and IMSI groups. Meta-analysis of five observational studies showed a significantly higher number of live births in the IMSI group than ICSI group (live birth rate odds ratio 1.47, 95% confidence interval 1.16-4.07), with a moderate degree of heterogeneity (I-2 = 41%). Additionally, from six observational studies, a significantly lower miscarriage rate was observed in the IMSI group than in the ICSI group (odds ratio 0.51, 95% confidence interval 0.37-.70, I-2 = 0%). Conclusions Meta-analysis of randomized studies comparing IMSI to ICSI has not shown any difference in live birth rate and miscarriage rate. Meta-analysis of observational studies, which must be interpreted with caution, revealed an increased live birth rate and decreased miscarriage rate with IMSI vs ICSI.
机译:引入血晶体形态所选择的精子注射(IMSI)是用于辅助再现的精子选择技术之一,其已应用于各种适应症,包括预先对氏菌精液注射(ICSI)的施肥失败的施肥。 Cochrane Review(1)发现精子选择的任何形式之间的结果没有差异。由于Cochrane评论发布,因此还有另外两项随机对照试验,比较IMSI和ICSI。该系统审查和META分析旨在将IMSI与ICSI与ICSI进行比较,作为关于活产率和流产率的授精方法。材料与方法系统审查2018年1月前发表的电子数据库的随机对照试验,观察研究和类似审查。结果我们发现九种随机对照试验,评估1610个体外施肥的循环和15个观察性研究评估1243个体外施肥的循环。随机随机对照试验的荟萃分析显示,ICSI和IMSI组之间的​​活率或流产率没有差异。五个观察性研究的Meta分析显示,IMSI组的活产量大于ICSI组(活速率率比1.47,95%置信区间1.16-4.07),具有中等程度的异质性(I-2 = 41%)。另外,从六种观察性研究,在IMSI组中观察到显着降低的流产率(在ICSI组中,在ICSI组中(0.51,95%,95%置信区间0.37-.70,I-2 = 0%)。结论将IMSI与ICSI比较的随机研究的荟萃分析尚未显示出生出生率和流产率的任何差异。荟萃分析的观察研究必须谨慎地解释,揭示了Live出生率增加,并降低了IMSI与ICSI的流产率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号